Molecular Biology Enzymes and Kits & Reagents Market - Industry Analysis, Market Size, Share, Trends, Growth And Forecast 2020 - 2025

Report Code: HCR 0456 Report Format: PDF + Excel (Delivery in 48 Hrs)
Molecular Biology Enzymes and Kits & Reagents Market Overview
Molecular Biology Enzymes and Kits & Reagents Market size is estimated to reach $21.04bn by 2025 and is poised to grow at a CAGR of 16.37% during the forecast period 2020-2025. Molecular biological enzymes are natural proteins produced by living organisms and are highly selective biochemical catalysts. Molecular biological reagents are chemicals used in molecular biological reactions to optimize the workflow. Molecular biology enzymes, kits and reagents are widely used for research, drug discovery, diagnostic testing. The fast-growing pharmaceutical and biotechnology industries are set to create significant opportunities for the development of molecular biology enzymes, kits, and reagents over the forecast period (2020-2025). The North American region accounted for highest revenue share in the year 2019 and is set to continue its growth over the forecast period 2020-2025.

Molecular Biology Enzymes and Kits & Reagents Market Report Coverage
The report: “Molecular Biology Enzymes and Kits & Reagents Market Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Molecular Biology Enzymes and Kits & Reagents Market.
By Product: Kits & Reagents, Enzymes. 
By Application: Polymerase chain reaction, Sequencing, Cloning, Epigenetics, Restriction Digestion, Synthetic Biology. 
By End-Use: Pharmaceutical and Biotechnology companies, Academic and Research institutes, Hospitals and Diagnostic centers and others. By Geography: North America, Europe, Asia-Pacific, and Rest of World.

Key Takeaways 
  • Geographically, The North American region accounted for highest revenue share in the year 2019 and is set to continue its growth over the forecast period 2020-2025 owing to high adoption of technology and increase in funding. The increased research activities and R&D investments in the life science industry are one amongst the many factors driving the market over the forecast period 2020-2025 (2020-2025). 
  • The lack of reimbursement for genetic testing is projected to have a negative impact on the global Molecular Biology Enzymes and Kits & Reagents market over the forecast period 2020-2025.
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Molecular Biology Enzymes and Kits & Reagents Market report. 

By Applications- Segment Analysis 
The global Molecular Biology Enzymes and Kits & Reagents market based on the Application type has Polymerase chain reaction (PCR), Sequencing, Cloning, Epigenetics, Restriction Digestion, and Synthetic Biology. Based on application, the Polymerase chain reaction had the largest market share in 2019, and is set to continue its growth over the forecast period 2020-2025. This is owing to increasing demand for molecular diagnostics and the detection of various diseases. Furthermore, the rise in funding for the manufacturers of PCR equipment’s is also driving the segment over the forecast period 2020-2025. The sequencing segment is projected to grow at the highest rate over the forecast period 2020-2025, primarily owing to increasing DNA sequencing with increasing genomic research, rapid technological development, and reduced sequencing costs. 

By Product – Segment Analysis 
Based on Product, the market is classified into Kits & Reagents, Enzymes. The Kits and reagents segment was dominant in terms of revenue in 2019. The low cost of kits and reagents and their reuse in everyday processes are the main factors driving this market. This segment is also set to grow at the fastest pace over the forecast period (2020-2025). The cost of producing reagents is significantly low, which further helps manufacturers to develop advanced products, which are also considered to be a leading factor driving the segment. 

By Geography - Segment Analysis
North America has dominated the market in 2019, and is estimated to grow over the forecast period 2020-2025. This is owing to the adoption of advanced technology and increasing funding for genomic research. In addition, expanding pharmaceutical companies in the US and increasing prevalence of the conditions involving molecular diagnostics are the factors projected to increase the market share over the forecast period (2020-2025). In addition, the Asia-Pacific market is projected to have the highest revenue growth in upcoming years. The increase in the geriatric population and increasing R&D investments is a major factor that is projected to contribute to the growth of the market over the forecast period 2020-2025.

Drivers – Molecular Biology Enzymes and Kits & Reagents Market
  • Increasing Funds in Research and Development 
Increasing R&D investment in the public and private sectors, as well as growth in R&D activities, are the main factors that are projected to contribute to the growth of the global market for molecular biology enzymes, kits and reagents over the forecast period 2020-2025. In addition, the increase in the incidence of chronic diseases and genetic disorders is another factor that is projected to support market growth over the forecast period 2020-2025.

Challenges – Molecular Biology Enzymes and Kits & Reagents Market 
  • Lack of Reimbursement 
The main challenge of this market is the lack of reimbursement for genetic testing which is projected to negatively impact the global market over the forecast period 2020-2025. The lack of high end technology to store genetic information is another factor which is likely to hinder the market growth over the forecast period 2020-2025.

Molecular Biology Enzymes and Kits & Reagents Market Industry outlook:
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Molecular Biology Enzymes and Kits & Reagents Market. Key companies of this market include Thermo Fisher, Merck, Illumina, QIAGEN, New England Biolabs, Promega, Agilent, Roche, Takara Bio, Bio Basic, Jena Bioscience, and Molecular Biology Resources. 

Acquisitions/Product Launches: 
  • In August 2020, Thermo Fisher Scientific Confirms Offer to Acquire QIAGEN Shares. 
  • In April 2020, New England Bio labs Introduces 100% Recyclable Packaging for Cold Chain Shipping in Partnership with TemperPack.
1. Molecular Biology Enzymes and Kits & Reagents Market - Overview
    1.1 Definitions and Scope
2. Molecular Biology Enzymes and Kits & Reagents Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product
    2.3 Key trends by Application
    2.4 Key trends by End-Use
    2.5 Key trends by Geography
3. Molecular Biology Enzymes and Kits & Reagents Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies 
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Molecular Biology Enzymes and Kits & Reagents Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Molecular Biology Enzymes and Kits & Reagents Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Molecular Biology Enzymes and Kits & Reagents Market - Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Molecular Biology Enzymes and Kits & Reagents Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Molecular Biology Enzymes and Kits & Reagents Market – By Product (Market Size –$Million/$Billion)
    8.1 Kits & Reagents
    8.2 Enzymes
        8.2.1 Polymerases
        8.2.2 Ligases
        8.2.3 Restriction Endonucleases
        8.2.4 Reverse Transcriptase’s
        8.2.5 Phosphatases
        8.2.6 Proteases and Proteinases
        8.2.7 Other Enzymes
9. Molecular Biology Enzymes and Kits & Reagents Market – By Application (Market Size –$Million/$Billion)
    9.1 Polymerase Chain Reaction
    9.2 Sequencing
    9.3 Cloning
    9.4 Epigenetics
    9.5 Restriction Digestion
    9.6 Synthetic Biology
10. Molecular Biology Enzymes and Kits & Reagents Market – By End-Use (Market Size –$Million/$Billion)
    10.1 Pharmaceutical and Biotechnology Companies
    10.2 Academic and Research Institutes
    10.3 Hospitals and Diagnostic Centers
    10.4 Others
11. Molecular Biology Enzymes and Kits & Reagents Market - By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 Rest of the World
        11.4.1 Middle East
        11.4.2 Africa
        11.4.3 South America
12. Molecular Biology Enzymes and Kits & Reagents Market - Entropy
13. Molecular Biology Enzymes and Kits & Reagents Market – Industry/Segment Competition Landscape Premium 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Molecular Biology Enzymes and Kits & Reagents Market – Key Company List by Country Premium Premium
15. Molecular Biology Enzymes and Kits & Reagents Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.